Panagora Asset Management’s ABVC BioPharma ABVC Stock Holding History

Panagora Asset Management’s Portfolio ABVC Stock Details ABVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58K	Buy	+36,682	New	+$45.7K	﹤0.01%	1156

Other funds holding ABVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Panagora Asset Management's ABVC Position: Q2 2026 in Review

Panagora Asset Management opened a new position in ABVC BioPharma (ABVC) in Q2 2026: 36,682 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #1156 among its holdings.

15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

Panagora Asset Management held 36,682 shares of ABVC BioPharma worth $58K as of Q2 2026.
ABVC BioPharma was a new Panagora Asset Management position in Q2 2026.
ABVC BioPharma made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1156 holding.
15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.